University of Cambridge

Focal Point Positioning

The University of Cambridge Enterprise Fund IV has invested in Focal Point Positioning Limited, a spin-out from the University of Cambridge.
Focal Point has developed software which offers highly accurate positioning of smartphones both indoors and outdoors in urban areas.
The company was founded in June 2015 with Dr Ramsey Faragher as CEO and CTO. The team […]

Polypharmakos

Cambridge and Kew join forces to find new antimicrobial substances in plants
The Parkwalk-mamanged University of Cambridge Enterprise Fund IV and Cambridge Enterprise have invested £500k in Polypharmakos Limited, a spin-out from the University of Cambridge and the Royal Botanic Gardens, Kew.
Polypharmakos’s mission is to screen natural-product sources of plant, fungal and insect origin for […]

Healthera

Healthera Ltd, a provider of next-generation, pharmacy-integrated personal health management solutions, has secured seed investment from the University of Cambridge, the University of Cambridge Enterprise Fund III, FT Capital and high net worth individuals. The specific amounts are undisclosed.

This round of institutional funding allows Healthera to complete its product development on the next generation […]

PervasID

PervasID  is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard.

Spun out from research activity in the Engineering Department at the University of Cambridge, the technology is now successfully deployed in several field trials.

PsyOmics

PsyOmics  is a University of Cambridge spin-out working to improve the prevention, diagnosis and treatment of neuropsychiatric disorders.

Mental illness accounts for over 15% of the disease burden in developed countries and in England alone, mental illness costs over £51.6bn per annum.

PsyOmics aims to deliver blood based biomarker diagnostics to:

Rapidly diagnose key mental health disorders
[…]

8Power

8Power is a University of Cambridge start-up developing novel technology for sensing and measurement in industrial applications.

The University of Cambridge is a world leader in the science and technology of sensing, and is pioneering the research of new sensor technologies applied to condition monitoring of built infrastructure and machinery through the Cambridge Centre for Smart […]

Cambridge Touch Technologies

Cambridge Touch Technologies (CTT) is a University of Cambridge start-up developing next-gen 3D touch technology.

CTT’s next generation 3D touch technology enables mobile devices to sense both the location and force of multi-touch inputs. CTT’s technology improves on the first generation of 3D technologies recently introduced to mass markets, which allow users to press a […]

Silicon Microgrvity

Spun-out of the University of Cambridge Nanoscience Centre, Silicon Microgravity is commercialising a sensor technology which provides a breakthrough in the management of oil and gas reservoirs.

The company’s breakthrough sensing technology combines the recording of gravity data at very high sensitivities and seismic data at low frequencies. Both sensing methodologies provide an improved means for […]

GeoSpock

GeoSpock, a spin-out from the University of Cambridge, provides a real-time scaleable database for rapidly changing complex data.  The company’s ambition is to become the Google Search of Big Data.

GeoSpock’s technology platform sits at the base of an infinite number of Industry verticals which require real-time analysis of Big Data and all that confers in […]

Cytora

Founded in early 2013, Cytora has built an event detection technology that can detect factual, real world events in unstructured text. The technology can be scaled to cover all major event categories and be monetised across the Financial Services, Defence and Supply Chain markets.

Extracting real world events from unstructured text also provides data for […]

Quethera

Quethera, a spin-out from the University of Cambridge, is a gene therapy company developing a novel treatment for glaucoma.

The company aims to deliver gene products for neuroprotectants and their receptors directly to the eye, which will provide long term neuroprotection to the retinal ganglion cells (RGC) in the eye, preventing their death and visual field loss. […]

Reduse

The Parkwalk-managed University of Cambridge Enterprise Fund III invested in Reduse in June 2015. In October 2016 the company entered voluntary liquidation.

Reduse, a spin out from the Low Carbon Materials Processing Group at the University of Cambridge, were seeking to change the way laser printed office paper is treated post use. Instead of disposal, recycling […]

PhoreMost

PhoreMost has developed a next-generation phenotypic screening platform called ‘Site-Seeker’ to identify the best new targets for future therapy, and crucially, how to drug them. This has the potential to significantly increase the diversity of novel therapeutics for cancer and other unmet diseases, where treatment options are currently severely limited.

PhoreMost believes it is uniquely placed […]

Fluidic Analytics

Fluidic Analytics is developing a line of tools for the rapid, accurate, cost-effective analysis of proteins and other biomolecular species. By combining a powerful microfluidics platform

RoadMap

RoadMAp - silicon wavelength switch technology

Jukedeck

VocalIQ - The world’s first platform that allows you to talk to your devices

Vocal IQ

VocalIQ - The world’s first platform that allows you to talk to your devices

AQDOT

Aqdot‘s technology allows for an energy- and raw material-efficient way of manufacturing microcapsules, leading to lower energy consumption and less waste.

Horizon Discovery

Horizon's basic science and translational research knowledge deployed in combination with best-in-class translational genomics platforms, products and services provides meaningful solutions to the challenges of translational researchers.

Sphere Fluidics

Sphere Fluidics has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services.